Press release
Histone Deacetylase Inhibitors Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024
Histone Deacetylase Inhibitors Market
Global histone deacetylase inhibitors market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over the 2018 to 2024
Market Outline: Global Histone Deacetylase Inhibitors Market
Histone deacetylase inhibitors are the products involved in inhibition of histone deacetylase, which removes acetyl groups from N-acetyl lysine amino acid present on the histone, and allows the histones to wrap DNA more tightly. Histone deacetylase inhibitors are used in the neurology and psychiatry as anti-epileptics and mood stabilizers. Moreover, these are also used in the treatment of cancer, parasitic, and inflammatory diseases.
Market Dynamics: Global Histone Deacetylase Inhibitors Market
Rise in prevalence of cancers and neurological disorders drives the global histone deacetylase inhibitors market. Moreover, increase in the R&D activities for the cancer treatment and other diseases, rise in demand to improve effectiveness of newer treatment therapies, and promising pipeline drugs, are anticipated to fuel the global histone deacetylase inhibitors market. However, lack of favorable reimbursement policies and uncertainty issues and stringent regulations for the product approval are restrain the growth of histone deacetylase inhibitors market over the forecast years.
Free sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/histone-deacetylase-inhibitors-market/#ulp-4H8Z4LpNMLEuOnnx
Market Scope: Global Histone Deacetylase Inhibitors Market
Histone deacetylase inhibitors market is segmented on the basis of drug class, application, and Distribution Channel
Based on the drug class, the market is segmented into the following:
• Class I
• Class II
• Class III
• Class IV
Based on the application, the market is segmented into the following:
• Neurology
• Oncology
• Others
Based on the distribution channel, the market is segmented into the following:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Free TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/histone-deacetylase-inhibitors-market/#ulp-c654SbFYO64MsOhu
Regional Analysis: Global Histone Deacetylase Inhibitors Market
Geographically, global histone deacetylase inhibitors market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America histone deacetylase inhibitors market is poised to grow at notable CAGR owing to increase in R&D for the development of newer drugs, rise in prevalence of cancer and neurological disorders, and high acceptance of HDAC products are expected to the boost the market. Europe histone deacetylase inhibitors market is rising due to increase in the aging population results to rise in prevalence of neurological disorders, grow in demand for advanced treatments, and pipeline drugs under the various stages of clinical trials are bolster the market. However, Asia Pacific histone deacetylase inhibitors market is poised to grow due to entry of market players into Asia Pacific countries with launch of newer products, rise in medical tourism for cancer treatment in Asia Pacific countries, and large patient pool are expected to offer healthy growth opportunities for the market.
Ask Analyst for Full Information about this report @
https://www.precisionbusinessinsights.com/market-reports/histone-deacetylase-inhibitors-market/#ulp-14mlyhjMGhVjZqa3
Competition Assessment: Global Histone Deacetylase Inhibitors Market
Some of the players in the global histone deacetylase inhibitors market include:
• Novartis AG (Switzerland)
• AstraZeneca Plc (U.K.)
• Pfizer, Inc. (U.S.)
• Celgene Corporation (U.S.)
• Eisai Co. Ltd. (Japan)
• Merck & Co., Inc. (U.S.)
• Acetylon Pharmaceuticals, Inc. (U.S.)
• Celleron Therapeutics Ltd. (U.K.)
• Innovation Pharmaceuticals, Inc. (U.S.)
• Ranedis Pharmaceuticals (U.S.)
Notable Market Developments: Histone Deacetylase Inhibitors Market
• In March 2017, AMO Pharma and Ranedis Pharmaceuticals entered into a collaboration to develop the RND-001, HDAC inhibitor, used in specific lysosomal storage disorders and neurodegenerative disorders
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/histone-deacetylase-inhibitors-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Histone Deacetylase Inhibitors Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 here
News-ID: 1076295 • Views: …
More Releases from Precision Business Insights
Gaming Controller Market Rising Demand for Gaming Stations and eSports
According to the Precision Business Insights (PBI), latest report the gaming controller market size was valued at USD 2,382.1 million in 2023, growing at an 8.5% CAGR from 2024 to 2030. The key drivers of the expansion of the global gaming controller include the enhanced gaming experience, technology advancements, consumer preferences and ergonomics, competitive gaming and esports, intuitiveness, and portability of the gaming controllers.
View Full Report: https://www.precisionbusinessinsights.com/market-reports/gaming-controller-market …
Next Generation Dietary Supplements Market Size, Growth Opportunities 2024-2030
According to Precision Business Insights (PBI), the latest report, the global next-generation dietary supplements market was valued at USD 10,752.3 million in 2023 and is expected to grow at a CAGR of 8.8% from 2024-2030. The primary factors that drive the market are the growing demand for rising consumer knowledge of the various health benefits of Next Generation Dietary Supplements, as well as rising disposable income levels, fuel market expansion…
Catamaran Market Increasing Popularity Of Water Sports And Fishing Activities
According to Precision Business Insights (PBI), the latest report, the catamaran market is valued at USD 1,635.7 million in 2023 and is anticipated to grow a CAGR of 4.9% over the forecast period. The primary factors that drive the market are the growing demand for Catamaran pushes the market to enhance efficiency, minimize time consumption, and reduce post-harvest operating losses. Catamaran are good solutions for reducing high labour costs since…
Refrigerated Display Cases Market Size, Share, Growth Trends and Forecast 2024-2 …
According to Precision Business Insights (PBI), latest report, the refrigerated display cases market was valued at USD 8,248.5 million in 2023 and is expected to grow at a 5.1% CAGR from 2024 to 2030. The primary drivers of the expansion of the global refrigerated display cases market include the increasing demand for frozen food and drinks among urban consumers. In addition, growing awareness about environment sustainability and energy efficiency is…
More Releases for Histone
Histone Deacetylase (HDAC) Inhibitors Market 2022 | Detailed Report
The Histone Deacetylase (HDAC) Inhibitors research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market's key players. Furthermore, the report offers insightful market data and information about the…
Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) Marke …
The Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) Market report offers an in-depth assessment of market dynamics, the competitive landscape, segments, and regions in order to help readers to become familiar with the Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) market. It particularly sheds light on market fluctuations, pricing structure, uncertainties, potential risks, and growth prospects to help players to…
Global Histone Deacetylase Inhibitors Market Research Report
This report studies the global Histone Deacetylase Inhibitors market status and forecast, categorizes the global Histone Deacetylase Inhibitors market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report 4SC AG Acetylon Pharmaceuticals Celleron Therapeutics Chroma Therapeutics CrystalGenomics Curis MEI Pharma Mirati Therapeutics Novartis…
Histone Deacetylase Inhibitors Market & Pipeline Insight2015
Histone Deacetylase (HDAC) are enzymes responsible for removal of acetyl groups present on acetyl lysine amino acid attached to histone. They are responsible for gene expression and regulation which is responsible for cellular functioning. It also helps in wrapping of histone over the Deoxyribonucleic acid (DNA). They are involved in cell growth and death which is responsible for maintaining steady state. Their involvement in diseases has been noted by investigators…
Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) - Pipeline …
The latest report Histone Deacetylase 4 - Pipeline Review, H1 2017, outlays comprehensive information on the Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviewsalso reviews key players involved in Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) targeted therapeutics development…
Global Histone Deacetylase Inhibitors Market
Histone deacetylase (HDAC) is enzymes, which inhibits histone deacetylase by removing scetyl group from n-acetyl lysine amino acid. Histone deacetylase inhibitors are emerging as potential application in diagnosis, treatment and prognosis of cancer. It is also considered as a treatment option for hematological malignancies and plays important role in epigenetic or non-epigenetic regulation. The histone deacetylase inhibitors accumulates acetylated nuclear histone in tumors and normal tissues. Thus, the inhabitation results…
